Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction

NCT07721545 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

944

Enrollment

INDUSTRY

Sponsor class

Conditions

Perforating Artery Infarction
PAI

Interventions

DRUG: Y-6 tablet
DRUG: Placebo

Sponsor

Neurodawn Pharmaceutical Co., Ltd.